Development of Amniotic Membrane-Derived Products to Drive Growth of Amniotic Membrane Market during 2020-2027
According to our new market research study titled Amniotic Membrane Market -Global Analysis and Forecast - by Enzyme, Application, and End User the global amniotic membrane market is expected to reach US$ 2,577.74 million by 2027 from US$ 1,484.83 million in 2019; it is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report highlights the trends prevalent in the global amniotic membrane market, and the drivers and deterrents pertaining to its growth.
The amniotic membrane-derived products are widely used in regenerative medicine. Moreover, several players operating in this market have developed and are developing amniotic membrane-derived products. For instance, SURGENEX, LLC, headquartered in the US, offers SurGraft - a dehydrated amniotic membrane sheet that has a wide application in wound management, ophthalmology, orthopedic surgery, and podiatry. It also provides SurFactor, an injectable amniotic tissue allograft that offers protective cushion to the damaged joints, tendons, cartilage, ligaments, and other soft tissues. Additionally, the company offers SurForce, a highly concentrated, cryopreserved, minimally manipulated, and biological injectable.
Similarly, the US-based Genesis Biologics provides amniotic fluid and amniotic membrane products that are used to treat conditions such as inflamed nerves, intra-articular pain, muscle tears, plantar fasciitis, repetitive motion injuries, soft tissue injuries, and tendonitis.
Further, an-vision GmbH, headquartered in Germany, offers Vetrix EyeQ amniotic eye drops that provides superior healing environment suitable for corneal tissue repair.
Thus, the growing trend of developing amniotic membrane-derived products is likely to favor the growth of the market during the forecast period.
The growth of the market is attributed to the factors such as growing applications of amniotic membrane and rising number of target patient population. However, the challenges in using amniotic membranes such compatibility are expected to hinder the market growth.
Applied Biologics LLC; Integra Life Sciences Corporation; Skye Biologics Inc.; MiMedx; Organogenesis Inc.; Smith & Nephew; Amniox Medical, Inc.; Katena Products. Inc.; Amnio Technology, LLC; and Surgenex, LLC are among the prominent players operating in the amniotic membrane market. The market players are focused on organic strategies to sustain their position in the market. For instance, in August 2020, TissueTech, Inc.'s proprietary PROKERA Slim corneal bandage, an amniotic membrane medical device was approved for eye care professionals' use in Taiwan.
The report segments the global amniotic membrane market as follows:
By Enzyme
By Application
By End User
By Geography
Reasons to Buy:
According to our new market research study titled Amniotic Membrane Market -Global Analysis and Forecast - by Enzyme, Application, and End User the global amniotic membrane market is expected to reach US$ 2,577.74 million by 2027 from US$ 1,484.83 million in 2019; it is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report highlights the trends prevalent in the global amniotic membrane market, and the drivers and deterrents pertaining to its growth.
The amniotic membrane-derived products are widely used in regenerative medicine. Moreover, several players operating in this market have developed and are developing amniotic membrane-derived products. For instance, SURGENEX, LLC, headquartered in the US, offers SurGraft - a dehydrated amniotic membrane sheet that has a wide application in wound management, ophthalmology, orthopedic surgery, and podiatry. It also provides SurFactor, an injectable amniotic tissue allograft that offers protective cushion to the damaged joints, tendons, cartilage, ligaments, and other soft tissues. Additionally, the company offers SurForce, a highly concentrated, cryopreserved, minimally manipulated, and biological injectable.
Similarly, the US-based Genesis Biologics provides amniotic fluid and amniotic membrane products that are used to treat conditions such as inflamed nerves, intra-articular pain, muscle tears, plantar fasciitis, repetitive motion injuries, soft tissue injuries, and tendonitis.
Further, an-vision GmbH, headquartered in Germany, offers Vetrix EyeQ amniotic eye drops that provides superior healing environment suitable for corneal tissue repair.
Thus, the growing trend of developing amniotic membrane-derived products is likely to favor the growth of the market during the forecast period.
The growth of the market is attributed to the factors such as growing applications of amniotic membrane and rising number of target patient population. However, the challenges in using amniotic membranes such compatibility are expected to hinder the market growth.
Applied Biologics LLC; Integra Life Sciences Corporation; Skye Biologics Inc.; MiMedx; Organogenesis Inc.; Smith & Nephew; Amniox Medical, Inc.; Katena Products. Inc.; Amnio Technology, LLC; and Surgenex, LLC are among the prominent players operating in the amniotic membrane market. The market players are focused on organic strategies to sustain their position in the market. For instance, in August 2020, TissueTech, Inc.'s proprietary PROKERA Slim corneal bandage, an amniotic membrane medical device was approved for eye care professionals' use in Taiwan.
The report segments the global amniotic membrane market as follows:
By Enzyme
- Cryopreserved Amniotic Membrane
- Dehydrated Amniotic Membrane
By Application
- Surgical Wounds
- Ophthalmology
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research Institute and Academic Institutes
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Asia Pacific (APAC)
- Japan
- China
- India
- Australia
- South Korea
- Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- South and Central America (SCAM)
- Brazil
- Argentina
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the amniotic membrane market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global amniotic membrane market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. Global Amniotic Membrane Market- Market Landscape
5. Amniotic Membrane Market - Key Market Dynamics
6. Amniotic Membrane Market - Global Analysis
7. Amniotic Membrane Market Analysis - By Enzyme
8. Amniotic Membrane Market Analysis - By Application
9. Amniotic Membrane Market Analysis - By End User
10. Amniotic Membrane Market Analysis And Forecasts To 2027 - Geographical Analysis
11. Impact of COVID-19 Pandemic on Global Amniotic Membrane Market
12. Amniotic Membrane Market - Industry Landscape
13. Company Profiles
14. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Applied Biologics LLC
- Integra Life Sciences Corporation
- Skye Biologics Inc.
- MiMedx
- Organogenesis Inc.
- Smith & Nephew
- Amniox Medical, Inc.
- Katena Products. Inc.
- Amnio Technology, LLC
- Surgenex, LLC